PTC Therapeutics (PTCT) was recently added to three Russell 2000 Defensive indexes, including value and growth focused ...
Zacks Investment Research on MSN
PTC Therapeutics (PTCT) upgraded to strong buy: Here's what you should know
PTC Therapeutics (PTCT) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #1 (Strong Buy). An upward trend in earnings estimates -- one of the most powerful forces ...
PTC (NASDAQ: PTC) will release its fiscal 2026 third quarter results on Wednesday, July 29th after the stock market closes.
PTC Therapeutics is entering a new phase following the launch of Sephience, with expanding commercial efforts and pipeline development shaping the company's next chapter.
Barchart on MSN
PTC Inc. earnings preview: What to expect
PTC Inc. (PTC), headquartered in Boston, Massachusetts, develops and delivers technology solutions, comprised of software and ...
PTC Inc. (NASDAQ:PTC) is one of the most promising stocks with highest upside potential. On June 11, PTC launched PTC Orbit, ...
Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and with ...
The partnership brings the Whatfix agentic digital adoption platform to users of PTC's product lifecycle management software ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results